Caribou Biosciences Inc (NASDAQ:CRBU) shares, rose in value on Thursday, March 27, with the stock price up by 12.21% to the previous day’s close as strong demand from buyers drove the stock to $0.99.
Actively observing the price movement in the last trading, the stock closed the session at $0.88, falling within a range of $0.885 and $1.01. The value of beta (5-year monthly) was 2.338. Referring to stock’s 52-week performance, its high was $5.23, and the low was $0.88. On the whole, CRBU has fluctuated by -17.61% over the past month.
With the market capitalization of Caribou Biosciences Inc currently standing at about $91.95 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-09.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 1.44M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CRBU’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of CRBU currently trading nearly -5.17% and -20.91% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 40.69, while the 7-day volatility ratio is showing 10.59% which for the 30-day chart, stands at 8.30%. Furthermore, Caribou Biosciences Inc (CRBU)’s beta value is 2.39, and its average true range (ATR) is 0.09.
A comparison of Caribou Biosciences Inc (CRBU) with its peers suggests the former has fared considerably weaker in the market. CRBU showed an intraday change of 12.21% in last session, and over the past year, it shrunk by -81.31%%.
Data on historical trading for Caribou Biosciences Inc (NASDAQ:CRBU) indicates that the trading volumes over the past 10 days have averaged 1.07 and over the past 3 months, they’ve averaged 1.27 million. According to company’s latest data on outstanding shares, there are 92.38 million shares outstanding.
Nearly 13.11% of Caribou Biosciences Inc’s shares belong to company insiders and institutional investors own 58.73% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 8.82 million shares as on 2025-03-14, resulting in a short ratio of 8.49. According to the data, the short interest in Caribou Biosciences Inc (CRBU) stood at 993.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 8.91 million. The stock has fallen by -37.82% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CRBU stock heading into the next quarter.